Guinea-Bissau vs Nicaragua: Previously treated cases tested for RR-/MDR-TB
Guinea-Bissau
54.0%
in 2024
Nicaragua
51.0%
in 2023
Guinea-Bissau rank
148th
Nicaragua rank
149th
Previously treated cases tested for RR-/MDR-TB over time
- Guinea-Bissau
- Nicaragua
How they compare
Guinea-Bissau currently reports 54.0% against 51.0% in Nicaragua, a difference of 3.0%.
That makes Guinea-Bissau's figure about 1.1 times Nicaragua's.
The two have swapped places 4 times across 10 shared years of data; in 2013 it was Nicaragua ahead.
Guinea-Bissau ranks 148th and Nicaragua ranks 149th of 180 countries.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.6% | 70.9% | 17.3% | Nicaragua |
| 2020s | 65.0% | 65.3% | 0.3% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea-Bissau or Nicaragua?
- Guinea-Bissau, at 54.0% against 51.0% in Nicaragua as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea-Bissau and Nicaragua?
- 3.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Nicaragua?
- 10 years are reported by both, from 2013 to 2022.
- How do Guinea-Bissau and Nicaragua rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea-Bissau ranks 148th and Nicaragua ranks 149th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.